Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irsogladine maleate for portal hypertensive gastropathy
jRCT1080224908Completed
- Sponsor
- Keiji Yokoyama
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of irsogladine in portal hypertensive gastropathy (PHG), sponsored by Keiji Yokoyama. Primary endpoint: Improvement in portal hypertensive gastropathy. Started Oct 2019; status: completed.
02
Drugs
irsogladine
03
Conditions
portal hypertensive gastropathy (PHG)
Beyond the preview
Go deeper on jRCT1080224908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224908.